Physical Exercise Program for Family Caregivers of Dependent Patients

Physical Exercise Program for Family Caregivers of Dependent Patients: Randomized Clinical Trial in Primary Health Care

This estudy evaluates the effects of physical exercise program on health related quality of life (HRQoL), pain and physical fitness in family caregiver.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Justification: Research indicates that the dependent patient caregiver´s have physical, psychological and social repercussions, as consequence of the care that they provide. From Primary Health Care there is a "caregiver care program" to prevent and palliate this situation, consisting mainly in education programs in care and psychotherapy. There is controversy about the effectiveness of these programs, being necessary to develop new therapeutic strategies.

Objectives: to determine the effects of a physical exercise program, adressed by the primary health care physioterapist, on health related quality of life (HRQol), pain and physical fitness in dependent patient caregivers included in the " caregiver care program" of a basic health area.

Methodology: randomized clinical trial, with control group (GC = 32) and intervention group (GI = 36), double blind and pre and post-intervention evaluation. The GC received the usual program of the " caregiver care program". The GI also carried out a multi-component exercise program for 12 weeks, with 3 weekly sessions realized in group and monitored by physiotherapists. The outcomes variables are measured by Quality of life (SF-36), Burden (Zarit), anxiety (Goldberg Ansiety Questionanaire), depression (Yesavage Questionnaire), pain intensity (EVA), disability (Roland Morris) and physical fitness (battery of fitness tests). Patients evaluator and Outcomes Assessor are masked.

Applicability of results: If the physical exercise program, carried out from the primary health care physiotherapy, improves the HRQol, pain and physical fitness, this intervention could be an effective therapeutic strategy in the "caregiver care programs". Furthermore the proposed intervention is simple, reproducible and requires few resources.

Study Type

Interventional

Enrollment (Actual)

68

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Valladlid
      • Valladolid, Valladlid, Spain, 47010
        • Gerencia de Atención Primaria Valladolid-Este

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Status as family caregiver and to be incluided in the "Caregiver care Program".
  • Provided care to family dependent al least 6 months.
  • Accept to participate in the study and sign the informed consent.
  • No changes in medication for at least 3 months prior to study entry.

Exclusion Criteria:

  • People whith associated pathologies that make it impossible to perform physical exercise program (moderate-intensity exercise).
  • To be incluiding in other family care program
  • Participation in any regular physical activity program.
  • To have a formal caregiver to care for the dependent family member

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: PE and PCFPC
Physical Exercise and primary care family caregivers program
Physical exercise program for familiy caregivers. 36 session physical exercise (3 sessions/week) performed by physioterapist. It incluided exercices to improve coordination, aerobic capacity, control motor and strenght
Usual Programe in primary care for family caregivers. 4 session (2 session/week). It incluides: ergonomy, postural hygiene, mobilitation of patients and self-care.
Active Comparator: Usual Care
Usual Care: PCFPC (primary care family caregivers program)
Usual Programe in primary care for family caregivers. 4 session (2 session/week). It incluides: ergonomy, postural hygiene, mobilitation of patients and self-care.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Health-related Quality of Life at different time point
Time Frame: Change from baseline to post-treatment (16 weeks from baseline).
Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) V2. Spanish version. The SF-36 is a 36- item scale constructed to survey health status and quality of life. It yields an 8-scale profile of functional health and well-being scores as well as psychometrically-based physical and mental health summary. Each scale is directly transformed into a 0-100 scale. Higher scores indicate better overall quality of life.
Change from baseline to post-treatment (16 weeks from baseline).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in burden caregiver at different time points
Time Frame: Change from baseline to post-treatment (16 weeks from baseline).
Zarit Carer Burden Interview. Spanish Version. It´s a questionnaire that evaluates carer burden and asks about many commonly reported difficulties faced by carers (intraclass correlation coefficient = .71). This questionnaire presents 22 Likert-type questions each of which has a score of 0 to 4. The total score can be from 0 to 88. Higher values indicate greater burden caregiver.
Change from baseline to post-treatment (16 weeks from baseline).
Changes in anxiety at different time points
Time Frame: Change from baseline to post-treatment (16 weeks from baseline).
Goldberg Anxiety Scale. Spanish version. It´s a self-reported measure that contains 9 questions designed to assed people anxiety. Scores range from 0-9. A higher score indicates a higher level anxiety
Change from baseline to post-treatment (16 weeks from baseline).
Changes in depression
Time Frame: Change from baseline to post-treatment (16 weeks from baseline).
The 15-item abbreviated version of the Geriatric Depression Scale (GDS), which measures depression (internal consistency, Cronbach's α = .80). A score of 4 or more has been reported to indicate clinical signs of depression.
Change from baseline to post-treatment (16 weeks from baseline).
Change in pain assesment at different simple points
Time Frame: Change from baseline to post-treatment (16 weeks from baseline).
Visual analog scale (VAS). The Vas is a 100 mm long horizontal line ranging from "0: no pain at all" on one end to "100: worst pain imaginable" on the other end. Participants mara a point along the line that best represents the pain they are experiencing at that moment. A higher score indicates a higher level of pain
Change from baseline to post-treatment (16 weeks from baseline).
Change in disability
Time Frame: Change from baseline to post-treatment (16 weeks from baseline).
Roland-Morris Disability Questionnaire (RMDQ).Spanish version. It is a self-administered disability questionnaire consisting of 24 questions that are specifically related to physical functions that may be affected by back pain. Score range from 0-24. A higher score indicates a higher level of Disability
Change from baseline to post-treatment (16 weeks from baseline).
Modifications of body mass index
Time Frame: Change from baseline to post-treatment (16 weeks from baseline).
Modification of the body mass index (BMI). Wheight in Kg and Height ill be combined to report BMI in kg/m^2
Change from baseline to post-treatment (16 weeks from baseline).
Changes in handgrip strength
Time Frame: Change from baseline to post-treatment (16 weeks from baseline).
Handgrip strength will be assess for both hands by using a hand dynamometer (TKK 5401, Japan) and the mean value of both hands (kg*m2) is considered to be outcome.
Change from baseline to post-treatment (16 weeks from baseline).
Changes in lower extremity function
Time Frame: Change from baseline to post-treatment (16 weeks from baseline).
Lower extremity function is assessed by using the "30 Second chair stand test". The patient is asked to stand upright from a standardized chair (0.43 m in height) with arms folded across the chest and to sit back down as many time as he can in 30 seconds.
Change from baseline to post-treatment (16 weeks from baseline).
Changes in postural balance
Time Frame: Change from baseline to post-treatment (16 weeks from baseline)
Postural balance is assessed by performing a blind flamingo test in which the barefoot subject stood with eyes closed on one leg, while the other leg is flexed at knee leven al held at the anckle by the hand of the same side of the body. The number of trials that the subject needed to complete 30 seconds of the static position is measured. The outcomes is expressed as number of trials
Change from baseline to post-treatment (16 weeks from baseline)
Changes in flexibility
Time Frame: Change from baseline to post-treatment (16 weeks from baseline).
Flexibility is assessed by using the "Sit and reach test". Here the distance between the tips of the fingers in the start to the final positions during this trunk flexion is recorded. The best result of two trials is considered the outcome.
Change from baseline to post-treatment (16 weeks from baseline).
Changes in mobility
Time Frame: Change from baseline to post-treatment (16 weeks from baseline).
Mobility is assessed by using the "Timed Up and Go test". This test involves getting out of a chair, walking 3 meters to and around a cone, and returning to the chair in the shortest time possible. The best score of two trials is recorded.
Change from baseline to post-treatment (16 weeks from baseline).
Changes in maximal oxygen uptake (Vo2 max)
Time Frame: Change from baseline to post-treatment (16 weeks from baseline).
Maximal oxygen uptake (Vo2 max) is assessed using the "2km Walking test " We perform the test based on the guidelines of the Afisal-Inefc Battery. For this purpose, a circuit is designed, is also used stopwatch (portable digital brand Oregon Scientific®, model SL929 Hockenheim Nero) with a precision of tenths of a second (0.1 sg) and heart rate monitors (Polar RS800 CX) to measure the heart rate at the end of the test. Procedure: The caregivers with comfortable clothes and shoes walk as fast as possible they could without running. Interpretation of the results: The time used to travel is recorded 2 kilometers, the heart rate corresponding to the end of the test expressed in beats per minute. If you spend more than 22 minutes completing the this test loses its validity. To calculate de maximal oxigen uptake (Vo2 max) this formula is used: Vo2max ( mi· kg·' ·min·' ) = 116,2 - 2,98*(time) - 0,11*(heart rate) - 0,14 (age) - 0,39*( body mass index)
Change from baseline to post-treatment (16 weeks from baseline).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Federico Montero Cuadrado, Castilla-León Health Service

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 14, 2015

Primary Completion (Actual)

June 20, 2016

Study Completion (Actual)

June 20, 2016

Study Registration Dates

First Submitted

September 14, 2018

First Submitted That Met QC Criteria

September 16, 2018

First Posted (Actual)

September 18, 2018

Study Record Updates

Last Update Posted (Actual)

September 18, 2018

Last Update Submitted That Met QC Criteria

September 16, 2018

Last Verified

August 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • GRS/VAE5-15

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Physical Activity

Clinical Trials on PE

Subscribe